AngioDynamics to Participate in Upcoming Investor Conferences
29 Julio 2024 - 3:15PM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative
medical technology company focused on restoring healthy blood flow
in the body’s vascular system, expanding cancer treatment options,
and improving quality of life for patients, today announced that
its management is scheduled to participate in the following
upcoming investor conferences:
9th Annual Needham Virtual MedTech & Diagnostics 1x1
Conference Date: August 12, 2024
Canaccord Genuity 44th Annual Growth Conference
Presentation: August 13, 2024 at 10:00am A live webcast of the
presentation will be accessible through the “Investors” section of
the Company’s website at www.angiodynamics.com.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology
company focused on restoring healthy blood flow in the body’s
vascular system, expanding cancer treatment options and improving
quality of life for patients.
The Company’s innovative technologies and devices are chosen by
talented physicians in fast-growing healthcare markets to treat
unmet patient needs. For more information, visit
www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240729308520/en/
Investors:
AngioDynamics, Inc. Stephen Trowbridge, Executive Vice President
& CFO (518) 795-1408
AngioDynamics (NASDAQ:ANGO)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
AngioDynamics (NASDAQ:ANGO)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
